Skip to main content

WATSON 837 15 Pill - pink u-shape

Pill with imprint WATSON 837 15 is Pink, U-shape and has been identified as Clorazepate Dipotassium 15 mg. It is supplied by Watson Pharmaceuticals.

Clorazepate is used in the treatment of Anxiety; Seizure Prevention; Alcohol Withdrawal; Epilepsy; Seizures and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 15 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 837 15

Clorazepate dipotassium 15 mg WATSON 837 15
Clorazepate dipotassium 15 mg WATSON 837 15 Front
Clorazepate dipotassium 15 mg WATSON 837 15 Back

Clorazepate Dipotassium

Imprint
WATSON 837 15
Strength
15 mg
Color
Pink
Shape
U-shape
Availability
Prescription only
Drug Class
Benzodiazepines
Pregnancy Category
N - Not classified
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
52544-0837 (Discontinued)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.